Get started
Author

Mats Fredriksen

Observed name: Fredriksen, Mats
ORCID: 0000-0002-8392-3366
Observed ORCID: 0000-0002-8392-3366
OpenAlex ID: A5032070271
Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD
2014 · Mats Fredriksen, Alv A. Dahl, et al. · ADHD Attention Deficit and Hyperactivity Disorders · 214
PDF
Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies
2012 · Mats Fredriksen, Anne Halmøy, et al. · European Neuropsychopharmacology · 182
Increased default-mode variability is related to reduced task-performance and is evident in adults with ADHD
2017 · Athanasia M. Mowinckel, Dag Alnæs, et al. · NeuroImage Clinical · 71
PDF
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): An open-label prospective study of time in treatment, dose, side-effects and comorbidity
2014 · Mats Fredriksen, Alv A. Dahl, et al. · European Neuropsychopharmacology · 65
Dialectical behavioral therapy-based group treatment versus treatment as usual for adults with attention-deficit hyperactivity disorder: a multicenter randomized controlled trial
2022 · Anne Halmøy, Anna Edith Ring, et al. · BMC Psychiatry · 55
PDF
Long‐Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study
2015 · Mats Fredriksen, Dawn E. Peleikis · Basic & Clinical Pharmacology & Toxicology · 31
PDF
A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study
2016 · Tor-Arne Hegvik, Kaya Kvarme Jacobsen, et al. · Journal of Neural Transmission · 17
PDF
Childhood trauma in adults with ADHD is associated with comorbid anxiety disorders and functional impairment
2021 · Dawn E. Peleikis, Mats Fredriksen, et al. · Nordic Journal of Psychiatry · 14
Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia—a randomized controlled trial
2023 · Therese Torgersen Bigseth, John Abel Engh, et al. · Frontiers in Psychiatry · 12
Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms
2021 · Therese Torgersen Bigseth, John Abel Engh, et al. · BMC Psychiatry · 12
PDF
Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study
2021 · Therese Torgersen Bigseth, Mats Fredriksen, et al. · Schizophrenia Research · 12
Individual Variability in Reaction Time and Prediction of Clinical Response to Methylphenidate in Adult ADHD: A Prospective Open Label Study Using Conners’ Continuous Performance Test II
2019 · Mats Fredriksen, Jens Egeland, et al. · Journal of Attention Disorders · 12
Impact of methylphenidate on sleep problems in adults with ADHD: a pilot polysomnography study
2020 · Mats Fredriksen, Neshat Golparian, et al. · Nordic Journal of Psychiatry · 9
PDF
Pharmacological Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD) in a Longitudinal Observational Study: Estimated Treatment Effect Strengthened by Improved Covariate Balance
2017 · Ole Klungsøyr, Mats Fredriksen · Open Journal of Statistics · 2
PDF
Exploring protocol development: Implementing systematic contextual memory to enhance real-time fMRI neurofeedback
2024 · Steffen Maude Fagerland, Henrik Røsholm Berntsen, et al. · Journal of Electrical Bioimpedance · 1
PDF
Trends in dispensing of medications used for ADHD in Norway, 2005–2025: a nationwide drug utilisation study
2026 · Espen Anker, Mats Fredriksen, et al. · BMC Pharmacology and Toxicology
Long‐Term Treatment Patterns in Norwegian ADHD ‐Medicine Users: A Cohort Register‐Based Study With 5 Years of Follow‐Up, 2012–2021
2026 · Espen Anker, Anne Halmøy, et al. · Pharmacoepidemiology and Drug Safety
PDF
Selective enhancement of cost sensitivity by methylphenidate in adult ADHD: a randomized placebo-controlled trial
2026 · Mads Lund Pedersen, Athanasia M. Mowinckel, et al. · Psychological Medicine
PDF
Svakt vitenskapelig grunnlag for kritikk av AD/HD-medisinering
2018 · Geir Øgrim, Michael B. Lensing, et al. · Tidsskrift for Den norske legeforening
PDF
Effects of group therapy in treatment of ADHD in adults
2016 · Anne Halmøy, Mats Fredriksen, et al. · http://isrctn.com/
Farmakoterapi hos voksne med AD/HD
2014 · Mats Fredriksen · Tidsskrift for Den norske legeforening
PDF
Mathematical modelling discriminates medication persisters from non-persisters in adult ADHD
2012 · Sigurd Ziegler, Mats Fredriksen, et al.
Works count: 35
Citation count: 709
H-index: 12
I10-index: 12
Year
Topic
Type